Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PET Coverage-With-Evidence Debate Continues: AHIP Urges Restraint

This article was originally published in The Gray Sheet

Executive Summary

Private insurers say data collected in a registry of Medicare cancer patients that have undergone positron emission tomography imaging does not support broader coverage of FDG-PET oncology applications
Advertisement

Related Content

PET Scan Registry Reports Two-Year Results; Medicare Policy Still Pending
PET Scan Registry Reports Two-Year Results; Medicare Policy Still Pending
MedCAC Says PET Data Is Too Weak To Remove Registry Requirement
CMS Reconsiders Data Collection Requirements For Oncologic PET Scans
CMS Reconsiders Data Collection Requirements For Oncologic PET Scans
Advertisement
UsernamePublicRestriction

Register

MT026724

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel